Professional Advisory Board Launch

FibroAction is proud to announce the launch of our Professional Advisory Board.

The Professional Advisory Board (PAB) will advise FibroAction's trustees/directors and it consists of professionals who have an interest in Fibromyalgia Syndrome (Fibro).

The founding members of FibroAction's PAB are:

Professor John E Davies MRCS D.Phys.Med FFSEM, a consultant Rheumatologist and Professor in Sports Medicine, who leads the NHS FMS Clinic at Guys Hospital, London and has been specifically treating Fibromyalgia Syndrome and Myofascial Pain patients for over a decade at his private clinics in London and Bristol.

Daniel Austen BSc, the Clinic Manager for the London and Bristol FM Clinics, headed up by Professor John E Davies. Daniel has a long history of setting up new or cutting edge medical treatments in the UK in both the NHS and Private sectors and he has Fibromyalgia Syndrome himself.

Dr Kim Lawson, BTech (Hons), PhD, of the Biomedical Research Centre, Sheffield Hallam University, is a research pharmacologist with an international reputation in Drug Discovery Research. Dr Lawson has research interests in the identification of novel targets for the development of drugs for the treatment of Fibromyalgia Syndrome.

Dr David Middlemiss, PhD, a Medicinal Chemist by training with 40 years experience in the Pharmaceutical industry. Dr Middlemiss is founder of XaviaPharm, an independent consultancy, which specializes in Medicinal Chemistry, Drug Discovery and strategic analysis. He is also a co-founder and Director of Theradeas Ltd., and Pharmadeas Ltd.

For more information, please see the Professional Advisory Board (PAB) Members section.